News and Announcements

GSK confirms guidance after strong first quarter

By Abigail Townsend

Date: Wednesday 30 Apr 2025

(Sharecast News) - GSK reiterated shrugged off the potential impact of tariffs on Wednesday and reiterated its full-year outlook, following a strong start to the year.
The blue chip drugs giant said total sales rose 2% in the first quarter, or by 4% on a constant currency basis, to £7.52bn.

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page